Oxford Asset Management’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Oxford Asset Management’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-226,200	Closed	-$23.2M	–	2083
2019 Q2	$23.2M	Hold	226,200	–	–	0.5%	13
2019 Q1	$25.8M	Buy	+226,200	New	+$16.6M	0.56%	16
2016 Q2	–	Sell	-20,774	Closed	-$613K	–	924
2016 Q1	$613K	Buy	+20,774	New	+$655K	0.02%	585

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Oxford Asset Management's ONCE Position: Q3 2019 in Review

Oxford Asset Management sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 226,200 shares — an estimated $23.2M sold.

Oxford Asset Management first reported a position in ONCE in Q1 2016 and held it in 3 quarters. The position peaked at $25.8M in Q1 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

Oxford Asset Management reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
Oxford Asset Management sold 226,200 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $23.2M.
Oxford Asset Management first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2016 and held it in 3 quarters.
Oxford Asset Management's Spark Therapeutics, Inc. Common Stock position peaked at $25.8M in Q1 2019.
184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.